BRIEF-Ligand Q3 adjusted earnings per share $0.69 (LGND)

Nov 9 (Reuters) - Ligand Pharmaceuticals Inc:

* Ligand reports third quarter 2017 financial results

* Q3 adjusted earnings per share $0.69

* Q3 earnings per share $0.36

* Q3 earnings per share view $0.61 -- Thomson Reuters I/B/E/S

* Sees FY 2017 revenue $134 million to $136 million

* Ligand Pharmaceuticals Inc - ‍total revenues for Q3 of 2017 were $33.4 million, compared with $21.6 million for same period in 2016​

* Ligand Pharmaceuticals Inc - ‍ligand updates guidance for 2017 revenue to be between $134 and $136 million​

* Ligand Pharmaceuticals Inc - ‍adjusted earnings per diluted share is now expected to be between $2.95 and $3.00 for 2017 ​

* Q3 revenue view $30.9 million -- Thomson Reuters I/B/E/S

* FY 2017 earnings per share view $2.95, revenue view $134.5 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

See Also:

• BRIEF-Killam Apartment REIT announces $70 mln public offering of trust units

• BRIEF-ChromaDex Q3 loss per share $0.07 from continuing operations

• BRIEF-Biocept reports Q3 loss per share $0.20